FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4283526995> ?p ?o ?g. }

• W4283526995 endingPage "14" @default.
• W4283526995 startingPage "1" @default.
• W4283526995 abstract "To study the effects of ubenimex (UBE) combined with pemetrexed (PEM) on lung adenocarcinoma cell behavior and its molecular mechanism, the tissue samples from lung adenocarcinoma patients who received PEM chemotherapy, those with PEM combined with UBE chemotherapy, and healthy volunteers were retrieved and analyzed. The expression levels of the suppressor of cytokine signaling 1 (SOCS1) in the human lung adenocarcinoma cancer cell lines A549 and PC-9 and tissues were detected by qRT-PCR. MTT assay was performed for cell proliferation. Cell apoptosis was detected by flow cytometry. Cell invasion ability was assessed using the Transwell assay. The expression levels of the JAK2/STAT3 signaling pathway proteins and apoptosis-related proteins were detected by Western blot. The antitumor effect of PEM combined with UBE was tested in nude mice using the tumor formation assay. Our results showed that UBE treatment, alone or combined with PEM, inhibited lung adenocarcinoma cell migration, invasion, and proliferation; promoted apoptosis; significantly increased the G0/G1-phase cell ratio; reduced the S-phase cell ratio; and inhibited the in vivo growth of tumor cells. UBE alone or in combination with PEM also inhibited the JAK2/STAT3 signaling pathway in lung adenocarcinoma cells. In addition, UBE combined with PEM therapy was associated with increased SOCS1 expression in patients’ serum and knocking down SOCS1 reversed the antitumor effects of UBE and PEM. Overall, combination therapy with UBE and PEM could inhibit the JAK2-STAT3 signaling pathway by upregulating SOCS1 expression to hinder the progression of lung adenocarcinoma cells." @default.
• W4283526995 created "2022-06-27" @default.
• W4283526995 creator A5001354020 @default.
• W4283526995 creator A5029360035 @default.
• W4283526995 creator A5037258424 @default.
• W4283526995 creator A5043936197 @default.
• W4283526995 creator A5067704471 @default.
• W4283526995 date "2022-06-25" @default.
• W4283526995 modified "2023-10-13" @default.
• W4283526995 title "Ubenimex Combined with Pemetrexed Upregulates SOCS1 to Inhibit Lung Adenocarcinoma Progression via the JAK2-STAT3 Signaling Pathway" @default.
• W4283526995 cites W1965464733 @default.
• W4283526995 cites W2001177765 @default.
• W4283526995 cites W2015807143 @default.
• W4283526995 cites W2020780403 @default.
• W4283526995 cites W2021029373 @default.
• W4283526995 cites W2037139573 @default.
• W4283526995 cites W2039152216 @default.
• W4283526995 cites W2041821070 @default.
• W4283526995 cites W2048214220 @default.
• W4283526995 cites W2054389025 @default.
• W4283526995 cites W2073220467 @default.
• W4283526995 cites W2079210999 @default.
• W4283526995 cites W2099530756 @default.
• W4283526995 cites W2104086720 @default.
• W4283526995 cites W2105067160 @default.
• W4283526995 cites W2105820269 @default.
• W4283526995 cites W2106787323 @default.
• W4283526995 cites W2129532336 @default.
• W4283526995 cites W2153512434 @default.
• W4283526995 cites W2163351155 @default.
• W4283526995 cites W2315531732 @default.
• W4283526995 cites W2519862065 @default.
• W4283526995 cites W2608152841 @default.
• W4283526995 cites W2770475050 @default.
• W4283526995 cites W2770621380 @default.
• W4283526995 cites W2792129694 @default.
• W4283526995 cites W2990042485 @default.
• W4283526995 cites W2990891703 @default.
• W4283526995 cites W3127361683 @default.
• W4283526995 cites W3161610310 @default.
• W4283526995 cites W3161688959 @default.
• W4283526995 cites W2798323364 @default.
• W4283526995 doi "https://doi.org/10.1155/2022/5614939" @default.
• W4283526995 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/35789603" @default.
• W4283526995 hasPublicationYear "2022" @default.
• W4283526995 type Work @default.
• W4283526995 citedByCount "0" @default.
• W4283526995 crossrefType "journal-article" @default.
• W4283526995 hasAuthorship W4283526995A5001354020 @default.
• W4283526995 hasAuthorship W4283526995A5029360035 @default.
• W4283526995 hasAuthorship W4283526995A5037258424 @default.
• W4283526995 hasAuthorship W4283526995A5043936197 @default.
• W4283526995 hasAuthorship W4283526995A5067704471 @default.
• W4283526995 hasBestOaLocation W42835269951 @default.
• W4283526995 hasConcept C121608353 @default.
• W4283526995 hasConcept C126322002 @default.
• W4283526995 hasConcept C14077384 @default.
• W4283526995 hasConcept C1491633281 @default.
• W4283526995 hasConcept C179185449 @default.
• W4283526995 hasConcept C185592680 @default.
• W4283526995 hasConcept C190283241 @default.
• W4283526995 hasConcept C2778923194 @default.
• W4283526995 hasConcept C2780783641 @default.
• W4283526995 hasConcept C2781182431 @default.
• W4283526995 hasConcept C29537977 @default.
• W4283526995 hasConcept C502942594 @default.
• W4283526995 hasConcept C55493867 @default.
• W4283526995 hasConcept C62112901 @default.
• W4283526995 hasConcept C62478195 @default.
• W4283526995 hasConcept C71924100 @default.
• W4283526995 hasConcept C86803240 @default.
• W4283526995 hasConcept C95444343 @default.
• W4283526995 hasConceptScore W4283526995C121608353 @default.
• W4283526995 hasConceptScore W4283526995C126322002 @default.
• W4283526995 hasConceptScore W4283526995C14077384 @default.
• W4283526995 hasConceptScore W4283526995C1491633281 @default.
• W4283526995 hasConceptScore W4283526995C179185449 @default.
• W4283526995 hasConceptScore W4283526995C185592680 @default.
• W4283526995 hasConceptScore W4283526995C190283241 @default.
• W4283526995 hasConceptScore W4283526995C2778923194 @default.
• W4283526995 hasConceptScore W4283526995C2780783641 @default.
• W4283526995 hasConceptScore W4283526995C2781182431 @default.
• W4283526995 hasConceptScore W4283526995C29537977 @default.
• W4283526995 hasConceptScore W4283526995C502942594 @default.
• W4283526995 hasConceptScore W4283526995C55493867 @default.
• W4283526995 hasConceptScore W4283526995C62112901 @default.
• W4283526995 hasConceptScore W4283526995C62478195 @default.
• W4283526995 hasConceptScore W4283526995C71924100 @default.
• W4283526995 hasConceptScore W4283526995C86803240 @default.
• W4283526995 hasConceptScore W4283526995C95444343 @default.
• W4283526995 hasFunder F4320323090 @default.
• W4283526995 hasLocation W42835269951 @default.
• W4283526995 hasLocation W42835269952 @default.
• W4283526995 hasLocation W42835269953 @default.
• W4283526995 hasOpenAccess W4283526995 @default.
• W4283526995 hasPrimaryLocation W42835269951 @default.
• W4283526995 hasRelatedWork W2348417465 @default.
• W4283526995 hasRelatedWork W2350294409 @default.

• next